EUVIMEDEUVIMED entdecken
Open Access

Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy

Subham Guin, Akash Ashokan, Alan Pollack, Shanta Dhar iD

ACS Pharmacology & Translational Science · 13.09.2024 · 7 (9) · 2820-2826

DOI: 10.1021/acsptsci.4c00301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 12.08.2024. Verfasst von Subham Guin und 3 weiteren Autor:innen. Beteiligte Einrichtung: NanoTherapeutics Research Laboratory, Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, Florida…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, Sylvester Comprehensive Cancer Center, University of Miami Health Systems.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • NanoTherapeutics Research Laboratory, Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, Florida 33136, United States.
  • Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida 33136, United States.
  • Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, Florida 33136, United States.

ORCID-Profile: Shanta Dhar

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Sylvester Comprehensive Cancer Center, University of Miami Health Systems

Zitieren

APA

Guin, S., Ashokan, A., Pollack, A., & Dhar, S. (2024). Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy. ACS Pharmacology & Translational Science, 7(9), 2820-2826. https://doi.org/10.1021/acsptsci.4c00301

Vancouver

Guin S, Ashokan A, Pollack A, Dhar S. Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy. ACS Pharmacology & Translational Science. 2024;7(9):2820-2826. doi:10.1021/acsptsci.4c00301

BibTeX
@article{Guin2024,
  author = {Guin, Subham and Ashokan, Akash and Pollack, Alan and Dhar, Shanta},
  title = {Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy},
  journal = {ACS Pharmacology & Translational Science},
  year = {2024},
  volume = {7},
  number = {9},
  pages = {2820--2826},
  doi = {10.1021/acsptsci.4c00301}
}
Kostenlos starten →